UPDATE 1-Celgene revenue rises less than expected due to strong dollar

April 28 (Reuters) - U.S. biotechnology company Celgene Corp

reported first-quarter revenue that fell just shy of

analysts estimates due to the stronger dollar, sending the

company's shares down 1.5 percent in premarket trading.

Read more